CD34+ cell enumeration in peripheral blood and apheresis samples, using two laboratory diagnostic kits or an institutional protocol

Bone Marrow Transplantation

Volumn 23, Issue 4, 1999, Pages 387-394

  Olivero, S ^a   Alario, T ^a   Ladaique, P ^a   Haccoun, M ^a   Viens, P ^a   Blaise, D ^a   Chabannon, C ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

Bone marrow transplantation; CD34; Diagnostic kits; Flow cytometry; Hematopoiesis; Peripheral blood stem cell

Indexed keywords

CD34 ANTIGEN;

APHERESIS; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL PROTOCOL; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL;

EID: 0032968405     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701583     Document Type: Article

References (31)

1. Goldman JM, Schmitz N, Niethammer D, Gratwohl A. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998; 21: 1-7.
2. + hematopoietic progenitor cells in peripheral blood and leukapheresis products by microvolume fluorimetry: a comparison with flow cytometry. J Hematother 1997; 6 :291-301.
3. + stem cells: evaluation and comparison of three methods. J Hematother 1997; 6: 213-26.
4. + cells in apheresis products from patients mobilized from peripheral blood progenitors with different regimens. Bone Marrow Transplant 1994; 13: 479-485.
5. Haas R, Möhle R, Frühauf S et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 83: 3787-3794.
6. Chabannon C, Le Coroller AG, Faucher C et al. Patient condition affects the collection of peripheral blood progenitors after priming with recombinant granulocyte colony-stimulating factor. J Hematother 1995; 4: 171-179.
7. Sienna S, Bregni M, Gianni AM. Estimation of peripheral blood CD34 positive cells for autologous transplantation in cancer patients. Exp Hematol 1993; 21: 203-205.
8. Krause D, Fackler MJ, Civin CI, May WS. Blood CD34: structure, biology, and clinical utility. Blood 1996; 87: 1-13.
9. Goodell MA, Rosenzweig M, Kim H et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nature Med 1997; 3: 1337-1345.
10. Bender JG, To LB, Williams S. Schwartzberg LS. Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1992: 1: 329-341.
11. Bensinger W. Appelbaum F, Rowley S et al. Factors that influence collection and engraftment of autologous peripheral blood stem cells. J Clin Oncol 1995; 13: 2547-2555.
12. + cells reinfused is the only factor predicting both granulocyte and platelet recovery. J Hematother 1996; 5: 663-670.
13. Weaver C, Hazelton B, Birch R et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995; 86: 3961-3969.
14. + cell determination for peripheral blood progenitor cell transplantation and correlation with clinical engraftment. Exp Hematol 1998; 26: 73-78.
15. + hematopoietic stem cells. J Hematother 1996; 5: 227-236.
16. + cell quantitation: an Australian multicenter study. J Hematother 1996; 5: 605-616.
17. Fritsch G, Buchinger P, Printz D. Use of flow cytometric CD34 analysis to quantify hematopoietic progenitor cells. Leuk Lymphoma 1993; 10: 443-451.
18. + cell enumeration in blood and leukapheresis products: report from the second nordic workshop. J Hematother 1996; 5: 237-245.
19. Knape CC. Standardization of absolute CD34 cell enumeration. J Hematother 1996; 5: 211-212.
20. + cell determination by flow cytometry. J Hematother 1996; 5: 231-236.
21. + cell enumeration (letter to the editor). J Hematother 1998; 7: 105-109.
22. Sienna S, Bregni M, Brando B et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 77: 400-409.
23. Bland JM, Altman D. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; I: 307-310.
24. + cells: comparison of methods. Transfusion 1997; 37: 775-784.
25. + cell estimation in leukapheresis products. Bone Marrow Transplant 1996; 18: 791-796.
26. + hematopoietic progenitor cell enumeration in a multicenter study. Cytometry 1997; 30: 109-117.
27. Beveridge R, Geller RB, Giguere J et al. CD34 enumeration in a multicenter study. J Hematother 1997; 6: 285-286.
28. + peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicenter study. Br J Cancer 1998; 78: 913-921.
29. Pecora AL, Negrin RS. CD34 enumeration (letter to the editor). J Hematother 1998; 7: 3.
30. Chin-Yee I, Anderson L, Keeney M, Sutherland DM, and the Canadian QASE Study Group. Quality assurance of stem cell enumeration by flow cytometry. Cytometry 1997; 30: 296-303.
31. Greaves MF, Titley I, Colman SM et al. CD34 Cluster Workshop Report. In: Schlossman SF, Boumsell L, Gilks W (eds). Leukocyte Typing V. White Cell Differentiation Antigens. Oxford University Press: Oxford, 1995, pp 840-846.